Enerzair capsules for inhalation contains three active substances called indacaterol, glycopyrronium and mometasone furoate. Indacaterol and glycopyrronium belong to a group of medicines called ...

All LABAs are associated with an increased risk of asthma-related deaths. Indacaterol is indicated for patients with COPD and not for patients with asthma. Indacaterol should not be used for ...

QVM149 is a triple therapy consisting of indacaterol (acetate), glycopyrronium (bromide) and mometasone (furoate), which is being developed as a daily inhaled treatment for asthma delivered via ...

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

Ultibro capsules for inhalation contain the active ingredients, indacaterol maleate and glycopyrronium bromide (glycopyrrolate) in a capsule form. The capsules are for oral inhalation only.

Review the side-effects of Indacaterol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...